This webinar provides expert insight from Dr. Richard L. Easton, Technical Director of Structural Analysis at BioPharmaSpec into using an Automated CE-SDS Platform in Efficient Biosimilar Comparability Studies
Richard provides data from studies with monoclonal antibodies, heavily glycosylated species and PEGylated species showing how the Maurice platform can be used to provide reliable insights into the structure of different types of biopharmaceuticals, including assessments of size heterogeneity, presence of partial species in monoclonal antibody preparations, impurity analyses and batch to batch comparability.
This webinar will benefit anyone who is interested in understanding how to optimise their analytical methods to accelerate biosimilar development.
